David B. Roberts - Nov 3, 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
President and Director, Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Nov 3, 2021
Transactions value $
-$753,917
Form type
4
Date filed
11/4/2021, 04:46 PM
Previous filing
Sep 13, 2021
Next filing
Dec 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $11.5K +1K +18.18% $11.43* 6.53K Nov 3, 2021 Direct F1
transaction LMAT Common Stock Options Exercise $264K +18.7K +286.62% $14.13* 25.2K Nov 3, 2021 Direct F1
transaction LMAT Common Stock Sale -$1.03M -19.7K -78.11% $52.24 5.52K Nov 3, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1K -100% $0.00* 0 Nov 3, 2021 Common Stock 1K $11.43 Direct F3
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -18.7K -72.55% $0.00 7.08K Nov 3, 2021 Common Stock 18.7K $14.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $51.78 to $53.50. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 This option is fully vested and exercisable.